Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick; Voorhees, Timothy; Kittai, Adam; Jain, Michael; Barba, Pere; IACOBONI, GLORIA

Ver

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma, 2024 (747.2Kb)

Autor

Fecha

2024-11-07

Enlace permanente

https://hdl.handle.net/11351/12439

DOI

10.1038/s41408-024-01183-8

ISSN

2044-5385

WOS

001352378700002

PMID

39511146

Registro Completo

Palabras clave

Células CAR-T; Linfoma difuso de células B grandes

Citación recomendada

Di Staso R, Casadei B, Locke FL, Jain M, Voorhees TJ, Kittai AS, et al. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma. Blood Cancer J. 2024 Nov 7;14:197.